Exelixis
EXEL
#1585
Rank
S$17.80 B
Marketcap
S$70.82
Share price
2.89%
Change (1 day)
27.14%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Exelixis (EXEL) - Total assets

Total assets on the balance sheet as of March 2026 : S$3.35 Billion

According to Exelixis's latest financial reports the company's total assets are S$3.35 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Exelixis - Total assets on balance sheet (from 2001 to 2026)

Total assets by year

Year Total assets Change
2025-12-31S$3.65 B-8.85%
2024-12-31S$4.00 B3.11%
2023-12-31S$3.88 B-5.63%
2022-12-31S$4.11 B16.42%
2021-12-31S$3.53 B25.09%
2020-12-31S$2.82 B11.22%
2019-12-31S$2.54 B30.84%
2018-12-31S$1.94 B121.69%
2017-12-31S$0.87 B1.65%
2016-12-31S$0.86 B83.41%
2015-12-31S$0.47 B10.06%
2014-12-31S$0.42 B-33.01%
2013-12-31S$0.63 B-27.69%
2012-12-31S$0.88 B73.15%
2011-12-31S$0.50 B9.59%
2010-12-31S$0.46 B-3.6%
2009-12-31S$0.48 B-16.06%
2008-12-31S$0.57 B-3.15%
2007-12-31S$0.59 B-2.19%
2006-12-31S$0.60 B9.45%
2005-12-31S$0.55 B16.55%
2004-12-31S$0.47 B-21.81%
2003-12-31S$0.60 B3.31%
2002-12-31S$0.58 B-8.3%
2001-12-31S$0.64 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
Johnson & Johnson
JNJ
S$259.77 B 7,645.79%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$268.47 B 7,905.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
S$119.61 B 3,466.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
S$191.60 B 5,613.24%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
S$166.40 B 4,861.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$111.82 B 3,234.22%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$107.66 B 3,110.19%๐Ÿ‡ฌ๐Ÿ‡ง UK
Curis
CRIS
S$35.74 M-98.93%๐Ÿ‡บ๐Ÿ‡ธ USA
AVEO Oncology
AVEO
S$0.13 B-96.10%๐Ÿ‡บ๐Ÿ‡ธ USA